Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer
Status:
Unknown status
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety and mechanisms of possible chemopreventive
effects of synthetic genistein (BONISTEIN™) in patients with localized prostate cancer
undergoing laparoscopic radical prostatectomy.